Blogging Layoffs Report San Diego 
Xconomy
OCTOBER 7, 2016
—The Institute for Clinical and Economic Review (ICER), whose drug-value analyses set the pharma industry’s teeth on edge , issued a new report on PD-1 inhibitors , part of the first wave of cancer immunotherapy drugs to be approved. . —The Nobel in Chemistry went to three scientists, in France, the Netherlands, and the U.S.,
Xconomy
JULY 1, 2016
But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster. —Buzzfeed ran a lengthy report Wednesday on the sexual harassment charges against University of Washington vaccine researcher Michael Katze.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JULY 1, 2016
Layoffs Reflect New Turbulence at High-Flying 3D Robotics. Frank Vinluan reports from North Carolina on a new effort to boost agtech startups and university research. San Antonio Entrepreneur Center Opens Using Dallas Nonprofit as Model. Bruce Bigelow lays out the business challenges of drone companies such as 3D.
Xconomy
JULY 15, 2016
Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. The week started on a reflective note. And then the news flowed, from a fast reprieve for Juno Therapeutics to no mercy for Elizabeth Holmes. —Enough good trial news.
Xconomy
MAY 22, 2017
Last week, the other shoe dropped with reports that Ford will cut 10 percent of its global hourly workforce while holding on to the tech talent it has recruited in the past few years to work on electric and self-driving cars. When Donald Trump heralded Ford’s announcement earlier this year that it would invest $1.2
Xconomy
JUNE 30, 2017
The nonpartisan Congressional Budget Office report Monday put the bill’s potential effects in stark relief: $321 billion in deficit reduction because of tax cuts and a Medicare rollback, and 22 million more people uninsured by 2026.
Xconomy
NOVEMBER 18, 2016
president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that naming-and-shaming—that is, Congress hauling executives into hearings and penning angry letters—certainly hasn’t done the trick. Speculation swirled this week around the incoming U.S.
Expert insights. Personalized for you.
77 
Let's personalize your content